CN Stock MarketDetailed Quotes

688526 Wuhan Keqian Biology Co.,Ltd

Watchlist

16.25
-0.38-2.29%

Market Closed Apr 30 15:00 CST

7.57BMarket Cap18.79P/E (TTM)

Wuhan Keqian Biology Co.,Ltd Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

Assets

Current assets

Money funds

-25.04%599.93M

-6.58%543.48M

-42.48%398.15M

64.50%688.95M

10.24%800.29M

27.56%581.74M

49.61%692.16M

-31.79%418.82M

32.74%725.98M

-17.88%456.07M

Transactional financial assets

1.65%706.58M

-3.43%719.51M

-26.64%667.65M

-18.63%645.32M

13.03%695.12M

10.40%745.04M

69.15%910.04M

188.48%793.04M

153.12%614.96M

216.90%674.83M

Notes receivable and accounts receivable

-11.47%276.54M

1.01%334.76M

-15.50%334.41M

-28.16%297.76M

-24.10%312.35M

-18.45%331.41M

-5.23%395.76M

16.90%414.46M

46.90%411.54M

47.62%406.38M

-Notes receivable

----

-58.43%43.37M

448.59%70.31M

1,005.53%82.67M

-Accounts receivable

-11.47%276.54M

1.01%334.76M

-15.50%334.41M

-19.76%297.76M

-8.46%312.35M

2.38%331.41M

26.79%395.76M

48.31%371.1M

27.64%341.23M

20.87%323.71M

Other receivables (including interest and dividends)

20.81%4.7M

30.64%4.87M

41.26%4.82M

17.33%4.9M

-6.99%3.89M

42.19%3.73M

52.92%3.41M

-17.28%4.18M

-5.31%4.18M

1.50%2.62M

-Other receivable

----

30.64%4.87M

----

17.33%4.9M

----

42.19%3.73M

----

-17.28%4.18M

----

1.50%2.62M

Advance payment

58.85%5.86M

-62.86%2.86M

-37.94%4.34M

-61.71%3.83M

-65.83%3.69M

-15.72%7.69M

-43.36%6.99M

5.68%10M

2.18%10.8M

-11.30%9.12M

Inventories

-15.32%124.01M

-13.26%125.6M

-29.26%110.57M

-18.21%133.64M

-15.70%146.44M

-14.52%144.8M

17.09%156.31M

35.99%163.4M

47.86%173.71M

55.68%169.4M

Receivable financing

619,195,491.90%61.92M

70.90%20.06M

--610

--5.28M

-100.00%10

8,256.80%11.74M

----

-82.23%2.84M

-99.27%140.44K

Non-current assets due within one year

58.88%769.22M

42.76%669.19M

-0.50%804.68M

-23.89%753.58M

-42.74%484.15M

-44.35%468.74M

162.06%808.71M

1,256.01%990.17M

47.32%845.47M

46.04%842.33M

Other current assets

20.79%32.43M

-80.55%52.76M

--71.95M

--38.09M

--26.85M

--271.2M

----

Total current assets

4.38%2.58B

-3.62%2.47B

-19.40%2.4B

-7.97%2.57B

-11.35%2.47B

0.20%2.57B

58.42%2.97B

92.28%2.79B

55.63%2.79B

45.40%2.56B

Non Current assets

Other equity investment

-25.48%74.44M

-38.82%59.08M

46,910.29%94.02M

50,370.91%100.94M

49,846.86%99.89M

48,185.89%96.57M

33.33%200K

Fixed assets

----

-8.04%734.74M

----

-9.97%755.65M

----

-9.27%799.01M

----

8.10%839.29M

----

70.85%880.59M

Constru in process

----

212.45%134.51M

----

693.78%74.7M

----

153.25%43.05M

----

-93.89%9.41M

----

-95.63%17M

Productive biological assets

17.33%10.3M

8.44%10.9M

-3.23%8.7M

--7.51M

--8.77M

--10.05M

--8.99M

----

Intangible assets

9.54%64.11M

8.45%65.1M

1.18%59.57M

-0.63%57.66M

-0.76%58.52M

0.19%60.03M

4.16%58.87M

0.96%58.03M

2.64%58.97M

4.67%59.91M

Goodwill

----

0.00%3.31M

--3.31M

Long deferred expense

31.63%1.46M

35.38%1.6M

--1.21M

--1.04M

--1.11M

--1.18M

----

Deferred tax assets

140.61%1.22M

219.86%959.24K

-99.46%189.36K

-99.23%246.87K

-98.25%505.2K

-98.88%299.89K

51.21%34.86M

64.13%31.87M

61.16%28.9M

64.69%26.8M

Usufruct assets

-0.95%6.54M

1.67%6.9M

-12.83%6.03M

-12.13%6.33M

-11.91%6.61M

-12.82%6.79M

6.20%6.92M

7.30%7.21M

--7.5M

--7.79M

Other non current assets

-10.39%1.02B

-7.00%1.01B

25.48%1.02B

13.19%892.11M

24.95%1.14B

30.06%1.08B

-33.97%811.77M

-43.51%788.13M

-12.86%910.66M

-15.42%834.13M

Total non current assets

-4.07%2.06B

-3.92%2.02B

15.36%2.04B

9.33%1.9B

13.96%2.15B

15.05%2.11B

-21.07%1.76B

-27.99%1.74B

-6.90%1.88B

-6.84%1.83B

Total assets

0.46%4.64B

-3.76%4.5B

-6.45%4.43B

-1.34%4.47B

-1.15%4.62B

6.39%4.67B

15.21%4.74B

17.22%4.53B

22.48%4.67B

17.86%4.39B

Liabilities

Current liabilities

Short term loan

----

-75.00%57.04M

-15.12%202.13M

-37.52%155.08M

57.02%206.65M

225.67%228.16M

693.18%238.15M

2,378.61%248.19M

629.98%131.6M

Notes payable and accounts payable

42.36%172.01M

8.02%178.26M

-24.92%135.18M

-34.48%123.55M

-45.80%120.83M

-32.44%165.03M

-29.47%180.04M

-22.58%188.58M

1.15%222.92M

13.22%244.27M

-Notes payable

214.80%53.71M

-1.92%32.07M

-54.02%18.51M

-20.59%17.48M

-59.83%17.06M

-31.88%32.69M

17.03%40.24M

-45.05%22.01M

85.22%42.47M

142.93%47.99M

-Accounts payable

14.01%118.3M

10.47%146.2M

-16.54%116.67M

-36.32%106.08M

-42.50%103.76M

-32.58%132.34M

-36.71%139.79M

-18.16%166.57M

-8.61%180.44M

0.15%196.27M

Contract liabilities

5.48%215.01M

-5.71%148.6M

-13.39%179.48M

25.88%172.48M

5.24%203.85M

54.97%157.61M

31.96%207.22M

63.25%137.02M

37.85%193.69M

60.96%101.7M

Salaries payable

33.12%27.41M

8.75%53.9M

-6.47%41.06M

-5.44%30.67M

-18.24%20.59M

0.33%49.57M

29.10%43.9M

10.68%32.44M

53.28%25.18M

0.73%49.41M

Taxs payable

-48.70%32.41M

-39.48%34.99M

-37.75%29.08M

-25.46%21.23M

184.43%63.18M

57.14%57.82M

88.56%46.71M

346.79%28.48M

14.24%22.21M

-31.64%36.79M

Other payable (including interest and dividends)

-15.94%33.88M

15.73%45.87M

-26.75%40.74M

-22.25%37.97M

-24.36%40.3M

-32.67%39.64M

41.06%55.62M

30.96%48.84M

93.65%53.28M

87.46%58.87M

-Other payable

----

15.73%45.87M

----

-22.25%37.97M

----

-32.67%39.64M

----

30.96%48.84M

----

87.46%58.87M

Non current liabilities due within one year

-95.59%1.38M

-98.33%1.35M

-98.47%1.24M

-38.85%31.21M

2,996.75%31.18M

12,416.81%81.11M

39,602.61%81.08M

81,425.93%51.04M

-97.49%1.01M

-98.92%648.04K

Other current liabilities

16.83%2.7M

-37.58%519.18K

-51.12%1.46M

61.07%1.17M

-24.27%2.31M

49.10%831.75K

-94.79%2.99M

-99.27%728.85K

-22.99%3.06M

-41.78%557.84K

Total current liabilities

-23.93%484.79M

-38.87%463.5M

-42.62%485.28M

-14.46%620.43M

-17.18%637.31M

21.55%758.25M

32.53%845.71M

36.57%725.28M

60.89%769.54M

26.73%623.84M

Current liabilities

Estimate liabilities

----

0.00%1.99M

Deferred tax liabilities

33.54%20.05M

36.57%17.71M

-74.03%15.06M

-81.22%11.18M

-74.23%15.01M

-77.18%12.97M

20.27%58M

46.61%59.53M

76.46%58.25M

91.55%56.84M

Long term deferred income

12.98%64.07M

16.63%66.04M

12.52%67.51M

17.99%69.38M

-7.32%56.71M

-8.26%56.62M

13.75%60M

7.54%58.8M

8.07%61.19M

29.94%61.72M

Lease liabilities

-2.10%5.56M

-3.47%5.55M

-15.36%5.44M

-16.56%5.42M

-15.44%5.67M

-19.32%5.75M

-2.71%6.43M

-2.28%6.5M

--6.71M

--7.12M

Total non current liabilities

15.86%89.67M

18.53%89.3M

-29.26%88.01M

-45.17%85.98M

-71.15%77.4M

-71.87%75.34M

13.56%124.42M

50.90%156.82M

192.78%268.25M

238.25%267.79M

Total liabilities

-19.62%574.46M

-33.68%552.8M

-40.91%573.29M

-19.92%706.41M

-31.13%714.71M

-6.51%833.59M

29.75%970.13M

38.92%882.11M

82.09%1.04B

56.04%891.63M

Shareholders equity

Paid-in capital

-0.01%466.13M

-0.01%466.17M

0.12%466.17M

0.23%466.21M

Capital reserve funds

-0.04%1.14B

0.49%1.14B

0.48%1.14B

0.65%1.13B

1.45%1.14B

1.84%1.14B

Surplus reserve funds

0.00%269.37M

17.82%269.37M

Retained profit

10.07%2.23B

9.43%2.12B

5.24%2B

6.16%1.89B

14.69%2.02B

18.89%1.93B

22.97%1.9B

25.41%1.78B

22.62%1.76B

20.82%1.63B

Less:Treasury stock

43.65%35.84M

5,950.21%34.77M

5,411.42%31.67M

2,633.29%30.58M

2,129.99%24.95M

-48.64%574.62K

-40.00%1.12M

Other composite income

-106.22%-1.78M

-167.66%-17.14M

--17.78M

--29.71M

--28.66M

--25.33M

----

Shareholders equity without minority interests

4.14%4.06B

2.75%3.94B

2.43%3.86B

3.16%3.76B

7.41%3.9B

9.69%3.84B

12.00%3.77B

12.98%3.65B

11.97%3.63B

10.89%3.5B

Minority interests

-14.62%1.6M

1.15%2.05M

-21.11%1.44M

-11.82%1.66M

-4.40%1.88M

-1.88%2.03M

-19.21%1.82M

-19.89%1.88M

297.69%1.96M

370.48%2.07M

Total shareholder equity

4.13%4.07B

2.75%3.94B

2.42%3.86B

3.15%3.76B

7.41%3.9B

9.68%3.84B

11.98%3.77B

12.96%3.65B

12.01%3.63B

10.94%3.5B

Total liabilityies and equity

0.46%4.64B

-3.76%4.5B

-6.45%4.43B

-1.34%4.47B

-1.15%4.62B

6.39%4.67B

15.21%4.74B

17.22%4.53B

22.48%4.67B

17.86%4.39B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Huaxing Certified Public Accountants Firm (Special General Partnership)

	(Q3)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022
Assets
Current assets
Money funds	-25.04%599.93M	-6.58%543.48M	-42.48%398.15M	64.50%688.95M	10.24%800.29M	27.56%581.74M	49.61%692.16M	-31.79%418.82M	32.74%725.98M	-17.88%456.07M
Transactional financial assets	1.65%706.58M	-3.43%719.51M	-26.64%667.65M	-18.63%645.32M	13.03%695.12M	10.40%745.04M	69.15%910.04M	188.48%793.04M	153.12%614.96M	216.90%674.83M
Notes receivable and accounts receivable	-11.47%276.54M	1.01%334.76M	-15.50%334.41M	-28.16%297.76M	-24.10%312.35M	-18.45%331.41M	-5.23%395.76M	16.90%414.46M	46.90%411.54M	47.62%406.38M
-Notes receivable	----	----	----	----	----	----	----	-58.43%43.37M	448.59%70.31M	1,005.53%82.67M
-Accounts receivable	-11.47%276.54M	1.01%334.76M	-15.50%334.41M	-19.76%297.76M	-8.46%312.35M	2.38%331.41M	26.79%395.76M	48.31%371.1M	27.64%341.23M	20.87%323.71M
Other receivables (including interest and dividends)	20.81%4.7M	30.64%4.87M	41.26%4.82M	17.33%4.9M	-6.99%3.89M	42.19%3.73M	52.92%3.41M	-17.28%4.18M	-5.31%4.18M	1.50%2.62M
-Other receivable	----	30.64%4.87M	----	17.33%4.9M	----	42.19%3.73M	----	-17.28%4.18M	----	1.50%2.62M
Advance payment	58.85%5.86M	-62.86%2.86M	-37.94%4.34M	-61.71%3.83M	-65.83%3.69M	-15.72%7.69M	-43.36%6.99M	5.68%10M	2.18%10.8M	-11.30%9.12M
Inventories	-15.32%124.01M	-13.26%125.6M	-29.26%110.57M	-18.21%133.64M	-15.70%146.44M	-14.52%144.8M	17.09%156.31M	35.99%163.4M	47.86%173.71M	55.68%169.4M
Receivable financing	619,195,491.90%61.92M	70.90%20.06M	--610	--5.28M	-100.00%10	8,256.80%11.74M	----	----	-82.23%2.84M	-99.27%140.44K
Non-current assets due within one year	58.88%769.22M	42.76%669.19M	-0.50%804.68M	-23.89%753.58M	-42.74%484.15M	-44.35%468.74M	162.06%808.71M	1,256.01%990.17M	47.32%845.47M	46.04%842.33M
Other current assets	20.79%32.43M	-80.55%52.76M	--71.95M	--38.09M	--26.85M	--271.2M	----	----	----	----
Total current assets	4.38%2.58B	-3.62%2.47B	-19.40%2.4B	-7.97%2.57B	-11.35%2.47B	0.20%2.57B	58.42%2.97B	92.28%2.79B	55.63%2.79B	45.40%2.56B
Non Current assets
Other equity investment	-25.48%74.44M	-38.82%59.08M	46,910.29%94.02M	50,370.91%100.94M	49,846.86%99.89M	48,185.89%96.57M	33.33%200K	33.33%200K	33.33%200K	33.33%200K
Fixed assets	----	-8.04%734.74M	----	-9.97%755.65M	----	-9.27%799.01M	----	8.10%839.29M	----	70.85%880.59M
Constru in process	----	212.45%134.51M	----	693.78%74.7M	----	153.25%43.05M	----	-93.89%9.41M	----	-95.63%17M
Productive biological assets	17.33%10.3M	8.44%10.9M	-3.23%8.7M	--7.51M	--8.77M	--10.05M	--8.99M	----	----	----
Intangible assets	9.54%64.11M	8.45%65.1M	1.18%59.57M	-0.63%57.66M	-0.76%58.52M	0.19%60.03M	4.16%58.87M	0.96%58.03M	2.64%58.97M	4.67%59.91M
Goodwill	----	----	0.00%3.31M	0.00%3.31M	0.00%3.31M	0.00%3.31M	0.00%3.31M	0.00%3.31M	--3.31M	--3.31M
Long deferred expense	31.63%1.46M	35.38%1.6M	--1.21M	--1.04M	--1.11M	--1.18M	----	----	----	----
Deferred tax assets	140.61%1.22M	219.86%959.24K	-99.46%189.36K	-99.23%246.87K	-98.25%505.2K	-98.88%299.89K	51.21%34.86M	64.13%31.87M	61.16%28.9M	64.69%26.8M
Usufruct assets	-0.95%6.54M	1.67%6.9M	-12.83%6.03M	-12.13%6.33M	-11.91%6.61M	-12.82%6.79M	6.20%6.92M	7.30%7.21M	--7.5M	--7.79M
Other non current assets	-10.39%1.02B	-7.00%1.01B	25.48%1.02B	13.19%892.11M	24.95%1.14B	30.06%1.08B	-33.97%811.77M	-43.51%788.13M	-12.86%910.66M	-15.42%834.13M
Total non current assets	-4.07%2.06B	-3.92%2.02B	15.36%2.04B	9.33%1.9B	13.96%2.15B	15.05%2.11B	-21.07%1.76B	-27.99%1.74B	-6.90%1.88B	-6.84%1.83B
Total assets	0.46%4.64B	-3.76%4.5B	-6.45%4.43B	-1.34%4.47B	-1.15%4.62B	6.39%4.67B	15.21%4.74B	17.22%4.53B	22.48%4.67B	17.86%4.39B
Liabilities
Current liabilities
Short term loan	----	----	-75.00%57.04M	-15.12%202.13M	-37.52%155.08M	57.02%206.65M	225.67%228.16M	693.18%238.15M	2,378.61%248.19M	629.98%131.6M
Notes payable and accounts payable	42.36%172.01M	8.02%178.26M	-24.92%135.18M	-34.48%123.55M	-45.80%120.83M	-32.44%165.03M	-29.47%180.04M	-22.58%188.58M	1.15%222.92M	13.22%244.27M
-Notes payable	214.80%53.71M	-1.92%32.07M	-54.02%18.51M	-20.59%17.48M	-59.83%17.06M	-31.88%32.69M	17.03%40.24M	-45.05%22.01M	85.22%42.47M	142.93%47.99M
-Accounts payable	14.01%118.3M	10.47%146.2M	-16.54%116.67M	-36.32%106.08M	-42.50%103.76M	-32.58%132.34M	-36.71%139.79M	-18.16%166.57M	-8.61%180.44M	0.15%196.27M
Contract liabilities	5.48%215.01M	-5.71%148.6M	-13.39%179.48M	25.88%172.48M	5.24%203.85M	54.97%157.61M	31.96%207.22M	63.25%137.02M	37.85%193.69M	60.96%101.7M
Salaries payable	33.12%27.41M	8.75%53.9M	-6.47%41.06M	-5.44%30.67M	-18.24%20.59M	0.33%49.57M	29.10%43.9M	10.68%32.44M	53.28%25.18M	0.73%49.41M
Taxs payable	-48.70%32.41M	-39.48%34.99M	-37.75%29.08M	-25.46%21.23M	184.43%63.18M	57.14%57.82M	88.56%46.71M	346.79%28.48M	14.24%22.21M	-31.64%36.79M
Other payable (including interest and dividends)	-15.94%33.88M	15.73%45.87M	-26.75%40.74M	-22.25%37.97M	-24.36%40.3M	-32.67%39.64M	41.06%55.62M	30.96%48.84M	93.65%53.28M	87.46%58.87M
-Other payable	----	15.73%45.87M	----	-22.25%37.97M	----	-32.67%39.64M	----	30.96%48.84M	----	87.46%58.87M
Non current liabilities due within one year	-95.59%1.38M	-98.33%1.35M	-98.47%1.24M	-38.85%31.21M	2,996.75%31.18M	12,416.81%81.11M	39,602.61%81.08M	81,425.93%51.04M	-97.49%1.01M	-98.92%648.04K
Other current liabilities	16.83%2.7M	-37.58%519.18K	-51.12%1.46M	61.07%1.17M	-24.27%2.31M	49.10%831.75K	-94.79%2.99M	-99.27%728.85K	-22.99%3.06M	-41.78%557.84K
Total current liabilities	-23.93%484.79M	-38.87%463.5M	-42.62%485.28M	-14.46%620.43M	-17.18%637.31M	21.55%758.25M	32.53%845.71M	36.57%725.28M	60.89%769.54M	26.73%623.84M
Current liabilities
Estimate liabilities	----	----	----	----	----	----	----	0.00%1.99M	0.00%1.99M	0.00%1.99M
Deferred tax liabilities	33.54%20.05M	36.57%17.71M	-74.03%15.06M	-81.22%11.18M	-74.23%15.01M	-77.18%12.97M	20.27%58M	46.61%59.53M	76.46%58.25M	91.55%56.84M
Long term deferred income	12.98%64.07M	16.63%66.04M	12.52%67.51M	17.99%69.38M	-7.32%56.71M	-8.26%56.62M	13.75%60M	7.54%58.8M	8.07%61.19M	29.94%61.72M
Lease liabilities	-2.10%5.56M	-3.47%5.55M	-15.36%5.44M	-16.56%5.42M	-15.44%5.67M	-19.32%5.75M	-2.71%6.43M	-2.28%6.5M	--6.71M	--7.12M
Total non current liabilities	15.86%89.67M	18.53%89.3M	-29.26%88.01M	-45.17%85.98M	-71.15%77.4M	-71.87%75.34M	13.56%124.42M	50.90%156.82M	192.78%268.25M	238.25%267.79M
Total liabilities	-19.62%574.46M	-33.68%552.8M	-40.91%573.29M	-19.92%706.41M	-31.13%714.71M	-6.51%833.59M	29.75%970.13M	38.92%882.11M	82.09%1.04B	56.04%891.63M
Shareholders equity
Paid-in capital	-0.01%466.13M	-0.01%466.13M	-0.01%466.13M	-0.01%466.17M	-0.01%466.17M	-0.01%466.17M	0.12%466.17M	0.23%466.21M	0.23%466.21M	0.23%466.21M
Capital reserve funds	-0.04%1.14B	-0.04%1.14B	0.49%1.14B	0.48%1.14B	0.48%1.14B	0.48%1.14B	0.65%1.13B	1.45%1.14B	1.84%1.14B	1.84%1.14B
Surplus reserve funds	0.00%269.37M	0.00%269.37M	0.00%269.37M	0.00%269.37M	0.00%269.37M	0.00%269.37M	17.82%269.37M	17.82%269.37M	17.82%269.37M	17.82%269.37M
Retained profit	10.07%2.23B	9.43%2.12B	5.24%2B	6.16%1.89B	14.69%2.02B	18.89%1.93B	22.97%1.9B	25.41%1.78B	22.62%1.76B	20.82%1.63B
Less:Treasury stock	43.65%35.84M	5,950.21%34.77M	5,411.42%31.67M	2,633.29%30.58M	2,129.99%24.95M	-48.64%574.62K	-48.64%574.62K	-40.00%1.12M	-40.00%1.12M	-40.00%1.12M
Other composite income	-106.22%-1.78M	-167.66%-17.14M	--17.78M	--29.71M	--28.66M	--25.33M	----	----	----	----
Shareholders equity without minority interests	4.14%4.06B	2.75%3.94B	2.43%3.86B	3.16%3.76B	7.41%3.9B	9.69%3.84B	12.00%3.77B	12.98%3.65B	11.97%3.63B	10.89%3.5B
Minority interests	-14.62%1.6M	1.15%2.05M	-21.11%1.44M	-11.82%1.66M	-4.40%1.88M	-1.88%2.03M	-19.21%1.82M	-19.89%1.88M	297.69%1.96M	370.48%2.07M
Total shareholder equity	4.13%4.07B	2.75%3.94B	2.42%3.86B	3.15%3.76B	7.41%3.9B	9.68%3.84B	11.98%3.77B	12.96%3.65B	12.01%3.63B	10.94%3.5B
Total liabilityies and equity	0.46%4.64B	-3.76%4.5B	-6.45%4.43B	-1.34%4.47B	-1.15%4.62B	6.39%4.67B	15.21%4.74B	17.22%4.53B	22.48%4.67B	17.86%4.39B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	--	--	--	--	Huaxing Certified Public Accountants Firm (Special General Partnership)	--	--	--	Huaxing Certified Public Accountants Firm (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

688526 Wuhan Keqian Biology Co.,Ltd

Wuhan Keqian Biology Co.,Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights

Discussing

Latest News

Investment Course